Biomarker in Blood Predicts Multiple Sclerosis Progression 1 to 2 Years in Advance
Researchers has found that elevated levels of NfL in the blood of multiple sclerosis (MS) patients could signal worsening disability within the next one to two years.
United States Jens Kuhle Suzanne Leigh Pascal Benkert Ahmed Abdelhak Swiss National Research Foundation
Source: neurosciencenews.com